➤ Treatment-induced fatigue is the most pervasive symptom of breast cancer chemotherapy experienced by women. ➤ Weight gain caused by breast cancer chemotherapy may have implications for morbidity and mortality from breast cancer and other chronic health problems. ➤ The menopausal side effects of chemotherapy coupled with changes in body appearance have a negative effect on sexuality. ➤ Exercise may be an intervention that can have a positive effect on this cluster of symptoms.
B
reast cancer treatments seldom produce a single symptom as their response. Rather, women respond to cancer therapy with symptoms that occur together in groups or clusters (American Cancer Society, 2003) . Fatigue, weight gain, and altered sexuality are frequent side effects of breast cancer treatment (Berger & Walker, 2001; Goodwin, 2001; Nail, 2002; Stead, 2003; Wilmoth & Tingle, 2001) . Barton-Burke (1997) postulated a link among fatigue, weight gain, and sexuality caused by cancer treatments (see Figure 1) ; however, the relationship has not been explored thoroughly.
The concept of symptom clusters has advanced the understanding of synergistic effects of cancer treatment side effects and has the potential to increase efficacy of nursing interventions (Dodd, Janson, et al., 2001) . A symptom cluster has been defined as three or more symptoms that are related and experienced concurrently. The treatment side effects all affect a patient at the same time and may even have an interactive effect on each other. The symptoms may not have the same etiology but do have a synergistic effect and may be broad predictors of morbidity (Dodd, Miaskowski, & Paul, 2001) . This article will explore the literature on fatigue, weight gain, and altered sexuality as a potential cluster of symptoms that affects women with breast cancer. An understanding of this symptom cluster will aid in directing limited resources toward designing innovative interventions for the more than 2 million breast cancer survivors in the United States (Schnipper, 2003) .
Fatigue
Cancer-related fatigue (CRF) is "a persistent, subjective sense of tiredness related to cancer or cancer treatment that interferes with usual functioning" (National Comprehensive Cancer Network [NCCN] , 2003, p. FT-1). The most common side effect of all cancer treatments, fatigue affects 70%-100% of patients with cancer receiving radiation therapy or chemotherapy (Bower et al., 2000; NCCN) . Many patients report that fatigue is more limiting than nausea and vomiting or pain and is not as well controlled (Stone, 2002) . Fatigue has been reported to be greater in those recently diagnosed with non-small cell lung cancer than those with newly diagnosed breast cancer (Stone, Richards, A'Hern, & Hardy, 2000).
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